Explore it now
26th Annual ESGO 2025 Congress
Discover it Now!
The aim of the study is to provide a collection of health-related routine data of patients treated for ovarian cancer to examine the quality of care during the process of a government-driven centralization (highly specialized medicine, HSM) in Switzerland.
Currently, advanced ovarian cancers in Switzerland are treated across various hospitals, without requiring a gynecological oncology specialization. To enhance care quality, the Swiss Government Health Organization (GDK) and Swiss-AGO have initiated a centralization process, allowing only specialized centers meeting specific criteria to perform ovarian cancer care. Centralization is expected to begin in Q3 of 2024, with quality control led by Prof. Heinzelmann-Schwarz.
Prof Viola Heinzelmann Schwarz
Prof Nicole Concin
Prof Ane Gerda Eriksson
Prof Christoph Grimm
Universitätsspital Basel Prof. Dr. med. Viola Heinzelmann-Schwarz
Inselspital Bern Prof. Dr. med. Michel Müller
Réseau hospitalier neuchâtelois RHNe Dr. med. Yves Brünisholz
SpitalSTS AG - Spital Thun Dr. med. Christoph Ackermann
Gynäkologisches Tumorzentrum Thurgau, Kantonsspital Münsterlingen / Frauenfeld Prof. Dr. med. Mathias Fehr
HFR hôpital fribourgeois - Hôpital cantonal, Bertigny Dr. med. Benedetta Guani
Stadtspital Zürich Triemli Dr. med. Natalie Gabriel
Spital Schwyz Dr. med. Georgios Gatopoulos
Kantonsspital Baden Prof. Dr. med. Martin Heubner
Kantonsspital St. Gallen Prof. Dr. med. René Hornung
Hôpital du Valais, CHVR - Hôpital de Sion Prof. Dr. med. Daniela Emanuela Huber
GZO, Spital Wetzikon Dr. med. Alexandra Johanna Kochanowski
Centre hospitalier universitaire vaudois Prof. Dr. med. Patrice Mathevet
Kantonsspital Winterthur Dr. med. Gesine Meili Anton
Hôpitaux universitaires de Genève Dr. med. Manuela Undurraga Malinoverno
Frauenzentrum Bern, Lindenhofgruppe Prof. Dr. med. Ralf Rothmund
Kantonsspital Aarau PD Dr. med. Dimitri Sarlos
Spital Grabs Prof. Dr. med. Seraina Schmid
Universitätsspital Zürich Prof. Dr. med. Isabell Witzel
EOC - Ospedale Regionale di Lugano Prof. Dr. med. Andrea Papadia
St. Claraspital Basel Prof. Rosanna Zanetti Dällenbach
As part of the project, ESGO and SWISS-AGO collect and register data from women treated for advanced ovarian cancer at centres participating in this study. By keeping strict personal data protection measures, ESGO and SWISS-AGO ensure transparent data processing and providese clear information to patients in compliance with all respective data protection regulations in place, in particular, EU Regulation 2016/679 (GDPR).
In view of the scientific research purposes, public interest in the field of public health, and ESGO and SWISS-AGO‘s legitimate interests in carrying out this research project, processing of personal data in the context of this retrospective study does not require the collection of patients' individual consent. General information about this study is publicly available at the centres participating in this study and on the ESGO website.
Any patient, however, may refuse to allow the inclusion of their data in this study. If you are a patient who objects to participation in this study, please contact your treating gynaecologist at your hospital. You can also object by filling in this objection form and emailing it to database@esgo.org. In such cases, your personal data will not be included in this study.
ESGO will create individual REDCap access for each centre.
Please reach out to us at database@esgo.org and provide the names and email addresses of all individuals responsible for data entry or otherwise requiring access from your centre.
Please refer to the instructions provided below for guidance on how to enter centre-level data.
Video tutorial how to enter centre-level data:
There are two ways to enter patient data.
Video tutorial how to enter individual patient data case by case:
If you encounter any issues or problems, please contact ESGO via database@esgo.org.
We are here to support you!